SOURCE: INC Research

INC Research

September 08, 2010 08:02 ET

INC Research to Present Value of Strategic Alliances for CROs and Sponsors in Exclusive Online Webinar

Large Pharma Joins to Discuss Sponsor Benefits; Registration Open for Free Webinar on Sept. 15, 2010

RALEIGH, NC--(Marketwire - September 8, 2010) -  INC Research ®, a therapeutically focused contract research organization (CRO) with a trusted process for delivering reliable results, is hosting an upcoming thought-leading webinar on "The Value of Strategic Alliances vs. Transactional CRO-Sponsor Relationships" on Wednesday, Sept. 15 at 1:00 pm EDT. Tim Dietlin, VP of Alliance Development at INC Research, will be joined by the global head of Clinical Contracting and Category Management for a large pharmaceutical company. They will define clinical delivery alliances and the value these alliance partnership models bring to the drug development process from both the sponsor and CRO perspective.

As drug development and outsourcing industries continue to mature and as cost pressures continue to increase, progressive players are starting to look for more value in their relationships. Per these industry movements, this webinar will discuss:

  • How do more strategic relationships positively affect performance and outcomes?
  • When do alliance partnerships make sense for a sponsor or a CRO?
  • What alliance partnership models are emerging, such as risk sharing, value-based pricing, bonus-malus, dedicated governance, deferred payments, etc.?
  • Lessons learned from current clinical delivery alliance models -- what works and what doesn't?
  • How both large pharma and biotechs can benefit from creative partnership structures and a process driven methodology for managing strategic development programs?

This 60-minute webinar presentation, promoted by Xtalks, will be held on Sept. 15, 2010, from 1:00 pm to 2:00 pm EDT. For more information about this upcoming webinar and how to register, click here.

To download "A New Approach to Outsourced Drug Development: How Sponsor-CRO Clinical Delivery Alliances Improve Performance," a white paper from INC Research, click here.

About INC Research® Inc.
INC Research is a therapeutically focused contract research organization (CRO) with a high performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in therapeutic areas of specialty, and in innovative pediatric and women's health trials. The company's The Trusted Process® methodology and therapeutic foresight leads customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, North Carolina. For more information please visit www.incresearch.com.

Contact Information